Biologic Active Ingredient for Specialty and Immunology Formulations
| Parameter | Specification |
|---|---|
| Appearance | Lyophilized powder / solution, biologic origin |
| Identification | Peptide mapping / ELISA compliant |
| Purity (SEC-HPLC) | ≥ 98.0% |
| Protein Content | As per certificate of analysis |
| Endotoxin | Within pharmacopoeial limits |
| Host Cell Protein | Within qualified limits |
| Storage | 2–8°C, protect from light |
Get Bulk Quote for Sotrovimab API
WHO-GMP certified · CoA + MSDS included · Ships to 40+ countries
For buyers evaluating Sotrovimab sourcing options, this page outlines our product profile, quality approach, and readiness to support ongoing procurement.
The Sotrovimab supply chain at Swapnroop is structured to minimise lead-time variability while keeping quality documentation available at every stage.
Consistent analytical performance and complete batch documentation are central to how we manage Sotrovimab from production through dispatch.
Packaging for Sotrovimab is selected to balance protection and practicality — HDPE/fiber drum options with inner liners are available depending on order size and destination.
Get Bulk QuoteOther APIs available from Swapnroop Pharma
The CAS number for Sotrovimab API is Available on Request (biologic). It is a biologic active ingredient manufactured by Swapnroop Drugs and Pharmaceuticals in Maharashtra, India.
Sotrovimab API is available in IP, BP, EP, and USP pharmacopeial grades where applicable with quality testing per pharmacopoeial and in-house specifications. All batches come with full CoA and MSDS.
Minimum order is 1 kg for sampling and 25 kg for commercial bulk supply. Standard lead time is 2–4 weeks from our Aurangabad, Maharashtra facility. Expedited supply is available for larger volumes.
Yes, Swapnroop provides full DMF-grade documentation for Sotrovimab API including CoA, MSDS, Genotoxic Impurity Report, Stability Data, and regulatory dossier support for USFDA, EMA, and CDSCO market submissions.
Yes, Swapnroop exports Sotrovimab API to 40+ countries including the USA, UK, UAE, Germany, Australia, South Africa, Nigeria, Kenya, Brazil, and Southeast Asian markets. We provide full export documentation and regulatory support.
For companies evaluating Sotrovimab API manufacturer options in India, this page offers a clear overview of the product profile, quality approach, and supply readiness.
Our team works with buyers who need Sotrovimab API backed by practical documentation support, organized batch handling, and efficient supply communication for ongoing business.